Navigation Links
WellGen, Inc. and RFI Ingredients to Collaborate on Therapeutic Nutrition Opportunities

Partnership will develop proprietary medical food, functional food, and dietary supplement products with strong scientific roots and clinical support for burgeoning markets

North Brunswick, NJ and Blauvelt, NY (PRWEB) December 17, 2009 -- WellGen, Inc., a biotechnology company at the crossroads of foods and pharmaceuticals, and RFI Ingredients, a manufacturer of innovative natural ingredients, are pleased to announce the signing of a Memorandum of Understanding (MOU) covering a range of areas for cooperation. The new partnership is designed to enhance the business of both companies and bring exciting new natural products to the market. Products will have a strong base in science, solid clinical support, and affirmed GRAS (generally recognized as safe) status.
The MOU serves as a framework for collaboration on several high-growth opportunities: the creation of new medical foods for people with inflammation-related diseases for which there are major unmet needs; the creation of new dietary supplement and functional food products for consumer and health care professional markets; and the development and supply of natural ingredients with strong scientific and clinical support.

Commenting on the new relationship, Dr. Roddy Carter, president and chief executive officer of WellGen, states “the complementary skills of WellGen and RFI Ingredients will work synergistically to enhance the companies’ natural product offerings. Both companies have been acknowledged for their innovation and share a common interest in developing proprietary, high-quality products supported by strong clinical evidence. This collaboration will couple WellGen’s scientific and clinical know-how with RFI’s infrastructure and expertise in the natural products market. “

WellGen uses proprietary biotechnology methods and a deep understanding of natural products chemistry to develop and distinguish natural materials which they market in products for therapeutic purposes. WellGen is focused on inflammation-related disease for their medical food products and is currently working on a new medical food for diabetes.

RFI Ingredients, a manufacturer of natural ingredients has created a supply chain model and infrastructure that focuses on vertical integration and enhanced control over raw materials. RFI has an excellent track record in the development and marketing of branded ingredients. They have broad capabilities in ingredient supply and several proprietary ingredients in their portfolio of products. While RFI’s core business is ingredient supply, they also have two consumer brands, SoTru and PhytoRich.

“The proprietary research that WellGen has been conducting over the past four years combined with RFI’s innovative ingredients and superior approach to sourcing will provide a significant competitive advantage for both companies as we pursue parallel market opportunities.” stated RFI chief executive officer/ president and founder Jeff Wuagneux.

About RFI Ingredients
RFI Ingredients is a vertically-integrated manufacturer of innovative natural ingredients for the food, functional food and dietary supplement industries. The company, which was formed in 1989, specializes in the supply of quality ingredients (including certified-organic) and proprietary formulations. For more information about RFI Ingredients, please see

About WellGen, Inc.
WellGen, Inc., based in North Brunswick, N.J., is a biotechnology company at the crossroads of foods and pharmaceuticals. Using the science of nutrigenomics, the company has developed Alignomx™, a proprietary bioinformatics model that uses gene expression data to determine optimal therapeutic areas for WellGen’s pipeline of proprietary natural products. Through its in-house expertise in nutrigenomics and natural product chemistry, WellGen is developing proprietary medical foods and has additionally identified several opportunities in the functional food and beverage and dietary supplement markets. For more information about WellGen, Inc., please see

# # #

Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. WellGen, Inc. Names Nancy E. Rawson, Ph.D., Chief Scientific Officer
2. WellGen, Inc. Names Robert M. Hellauer as Chief Financial Officer
3. Dr. Roddy Carter Named President and Chief Executive Officer of WellGen, Inc.
4. WellGen, Inc. Launches Te Ame(TM) Nutritional Supplements With Proven Health Benefits of Proprietary Black Tea Extract
5. The Omega-3 Industry Leader, Croda Health Care, selects Neptune Technologies Ingredients for New Essentially Brand
6. Atrium completes the sale of its Active Ingredients and Specialty Chemicals division
7. Quantum dots and nanomaterials: Ingredients for better lighting and more reliable power
8. Microbia, Inc. Names Mike Doyle as Senior Vice President and General Manager, Nutrition Ingredients
9. The Global Active Pharmaceutical Ingredients (API) Market: A Frost & Sullivan Briefing on Changing Dynamics
10. Ajinomoto Food Ingredients LLC Expands Capabilities
11. InVitrias Better Ingredients for Better Media to be Showcased at BPI 09
Post Your Comments:
Related Image:
WellGen, Inc. and RFI Ingredients to Collaborate on Therapeutic Nutrition Opportunities 
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
(Date:6/23/2016)... SILVER SPRING, Md. , June 23, 2016 ... evidence collected from the crime scene to track the criminal ... sick, and the U.S. Food and Drug Administration (FDA) uses ... Sound far-fetched? It,s not. ... whole genome sequencing to support investigations of foodborne illnesses. Put ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, doctors ... being treated for breast cancer benefitted from an injection of stem cells derived from ... frequent side effect of cancer treatment. , Lymphedema refers to the swelling ...
Breaking Biology Technology:
(Date:6/9/2016)... June 9, 2016 Paris ... Teleste,s video security solution to ensure the safety of people ... during the major tournament Teleste, an international ... and services, announced today that its video security solution will ... to back up public safety across the country. The system ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... Dollar project, for the , Supply and Delivery ... IT Infrastructure , to Decatur ... Identity Management Solutions. Numerous renowned international vendors participated in the ... was selected for the most compliant and innovative solution. The ...
(Date:6/1/2016)... -- Favorable Government Initiatives Coupled With Implementation ... to Boost Global Biometrics System Market Through 2021  ... " Global Biometrics Market By Type, By End ... - 2021", the global biometrics market is projected to ... growing security concerns across various end use sectors such ...
Breaking Biology News(10 mins):